Copyright
©2013 Baishideng Publishing Group Co.
World J Clin Pediatr. Aug 8, 2013; 2(3): 16-25
Published online Aug 8, 2013. doi: 10.5409/wjcp.v2.i3.16
Published online Aug 8, 2013. doi: 10.5409/wjcp.v2.i3.16
Instrument | Administration method(time) | Children with severe or profound ID included (Y/N) | Measured prevalence of autism in TSC (N) | Ref. |
ADOS | Observation schedule (20-30 min) | N | 29% (28) +ADI | [18] |
15-33% (4 age-based groups of 12-15) | ||||
ADI | Structured Interview (2-3 h) | Y-severe | 54% (13) | [15,16] |
20% (20) | ||||
SRS | 65-item Screening Questionnaire (15-20 min) | N (37 w/IQ data) | 52% (21) | [22] |
SCQ | 40-item Screening Questionnaire (15-20 min) | Y-severe | 43% (21) | [22] |
Hunt and Dennis Questionnaire | 321 item interview/13-item subset for autism (1-4 h) | Y-estimates only | 50% (90) | [2,9,14,23] |
26% (23) | ||||
24% (21) | ||||
5% (131) | ||||
DSM III-R | Checklist (10-20 min) | Y-severe | 61% (28) | [3] |
- Citation: Gipson TT, Gerner G, Wilson MA, Blue ME, Johnston MV. Potential for treatment of severe autism in tuberous sclerosis complex. World J Clin Pediatr 2013; 2(3): 16-25
- URL: https://www.wjgnet.com/2219-2808/full/v2/i3/16.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v2.i3.16